Medicinal Cannabis Cultivation – Training Courses and Forums in 2020

End of Year Dinner

Medicinal Cannabis Cultivation Training Courses and Forums | 2020 Dates

PharmOut will again host next year’s pharmaceutical / medicinal cannabis cultivation training course to help growers and pharmaceutical companies understand the extensive regulatory requirements for growing and producing medicinal cannabis products in the Australian and New Zealand regions.

The March 2020 course, being held at the Soffitel Hotel on Collins Street in Melbourne, will focus on the cultivation, production and manufacture of Medicinal Cannabis, the practical questions around the most efficient facility design and your design choices within the constraints of the ODC and TGA regulations. We will discuss practical problems you may face as you design, build, validate and operate your Medicinal Cannabis facility.

Facilitating the training will be Trevor Schoerie, arguably the leading Australian Medicinal Cannabis Consultant, and several other expert consultants for the medicinal cannabis and pharmaceutical manufacturing industry.

View additional course details and topics being covered.


ALSO coming soon – PharmOut’s Australia Medicinal Cannabis Cultivation Training Courses (Medicinal Cannabis Industry Training Courses in Australia).


medicinal-cannabis-cultivation-conference

A little about IDT – Sponsor of last year’s events

Founded in 1975 IDT Australia is an innovative science and technology company providing expert pharmaceutical services both locally and globally, specialising in high containment, high potency manufacture of API and finished dose products (including beta lactams), microbiological and analytical testing, clinical packaging, and pharmacy services. IDT is the partner of choice for pharmaceutical companies worldwide offering a flexible comprehensive service from early stage API development through to finished drug formulation, clinical trial research and scaled commercial manufacturing for global distribution and initial drug development through to clinical trials in their fully cGMP compliant facilities.

Today, the IDT business includes:

  • Research and Development
  • Active pharmaceutical ingredient (API) and finished dosage form manufacture, clinical and commercial
  • Project Management
  • Chemical Services
  • Analytical Chemistry
  • Pharmaceutical development in all dosage forms
  • Clinical packaging for early phase clinical trials

For more information about IDT visit: www.idtaus.com.au

Last year’s event information (from our Archives)

Speakers at last year’s event included Trevor Schoerie, talking about how the medical cannabis industry will disrupt a number of industries. We are already seeing the impact of the medicinal cannabis industry on the Pharmaceutical employment market and the predicted growth over the last few years.

This event will make for an interesting and fascinating evening for those interested in this rapidly expanding, new industry. This expansion is creating wonderful opportunities for traditional pharmaceutical professionals looking for new challenges and opportunities.

We also heard from John Ryan, CEO of the Penington Institute around the growing issue of prescription drug addiction. Opioid-related deaths are increasing rapidly in the United States and now becoming an issue here in Australia.

PharmOut’s Learning and Development Director Maria Mylonas, who was hot off the plane from the UK, also provided an update on her trip to the MHRA GMDP Symposium held 19-22 November in London. Maria presented the top GDP and GMP audit findings as we headed into full implementation of PIC/S version 13 (1st January 2019).

Want to attend our next cannabis event?

Visit our Cannabis conferences in 2020 pages or National GMP Forum.

You can also read our top 10 Australia Medicinal Cannabis Industry Blogs